Hygeia Healthcare Holdings Dirección
Dirección controles de criterios 4/4
El CEO de Hygeia Healthcare Holdings' es Yiwen Zhu , nombrado en Aug 2021, tiene una permanencia de 2.67 años. compensación anual total es CN¥3.73M, compuesta por 13.2% salario y 86.8% primas, incluidas acciones y opciones de la empresa. posee directamente un 44.38% de las acciones de la empresa, por valor de HK$8.20B. La antigüedad media del equipo directivo y de la junta directiva es de 3 años y 4.4 años, respectivamente.
Información clave
Yiwen Zhu
Chief Executive Officer (CEO)
CN¥2.5m
Compensación total
| Porcentaje del salario del CEO | 24.1% |
| Permanencia del CEO | 2.8yrs |
| Participación del CEO | 44.4% |
| Permanencia media de la dirección | 3.3yrs |
| Promedio de permanencia en la Junta Directiva | 4.5yrs |
Actualizaciones recientes de la dirección
Recent updates
Market Participants Recognise Hygeia Healthcare Holdings Co., Limited's (HKG:6078) Earnings Pushing Shares 28% Higher
May 06
Is Hygeia Healthcare Holdings (HKG:6078) Using Too Much Debt?
Apr 24Hygeia Healthcare Holdings Co., Limited Just Missed EPS By 7.5%: Here's What Analysts Think Will Happen Next
Mar 29Hygeia Healthcare Holdings Co., Limited (HKG:6078) Shares Could Be 41% Below Their Intrinsic Value Estimate
Feb 27Hygeia Healthcare Holdings Co., Limited (HKG:6078) Stocks Pounded By 25% But Not Lagging Market On Growth Or Pricing
Jan 09Returns On Capital Are Showing Encouraging Signs At Hygeia Healthcare Holdings (HKG:6078)
Dec 04Is Hygeia Healthcare Holdings Co., Limited (HKG:6078) Trading At A 48% Discount?
Oct 23Does Hygeia Healthcare Holdings (HKG:6078) Deserve A Spot On Your Watchlist?
Sep 21There's Been No Shortage Of Growth Recently For Hygeia Healthcare Holdings' (HKG:6078) Returns On Capital
Aug 31Calculating The Fair Value Of Hygeia Healthcare Holdings Co., Limited (HKG:6078)
Jul 21Should You Be Adding Hygeia Healthcare Holdings (HKG:6078) To Your Watchlist Today?
Jun 14Does This Valuation Of Hygeia Healthcare Holdings Co., Limited (HKG:6078) Imply Investors Are Overpaying?
Apr 18Do Hygeia Healthcare Holdings' (HKG:6078) Earnings Warrant Your Attention?
Feb 21Investors Will Want Hygeia Healthcare Holdings' (HKG:6078) Growth In ROCE To Persist
Dec 03Hygeia Healthcare Holdings Co., Limited (HKG:6078) Shares Could Be 31% Below Their Intrinsic Value Estimate
Nov 02Hygeia Healthcare Holdings (HKG:6078) Is Doing The Right Things To Multiply Its Share Price
Aug 09Hygeia Healthcare Holdings (HKG:6078) Shareholders Will Want The ROCE Trajectory To Continue
May 02After Leaping 58% Hygeia Healthcare Holdings Co., Limited (HKG:6078) Shares Are Not Flying Under The Radar
Apr 13Investors Will Want Hygeia Healthcare Holdings' (HKG:6078) Growth In ROCE To Persist
Jan 11Are Investors Undervaluing Hygeia Healthcare Holdings Co., Limited (HKG:6078) By 21%?
Nov 23With EPS Growth And More, Hygeia Healthcare Holdings (HKG:6078) Is Interesting
Oct 28Hygeia Healthcare Holdings (HKG:6078) Shareholders Will Want The ROCE Trajectory To Continue
Sep 02A Look At The Intrinsic Value Of Hygeia Healthcare Holdings Co., Limited (HKG:6078)
Aug 20Here's Why We Think Hygeia Healthcare Holdings (HKG:6078) Is Well Worth Watching
Jul 20Hygeia Healthcare Holdings Co., Limited Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Mar 31Hygeia Healthcare Holdings Co., Limited (HKG:6078) Insiders Increased Their Holdings
Mar 02Are Hygeia Healthcare Holdings Co., Limited (HKG:6078) Investors Paying Above The Intrinsic Value?
Jan 26
With A 0.8% Return On Equity, Is Hygeia Healthcare Holdings Co., Limited (HKG:6078) A Quality Stock?
Jan 05Are Hygeia Healthcare Holdings's (HKG:6078) Statutory Earnings A Good Guide To Its Underlying Profitability?
Dec 15Is Hygeia Healthcare Holdings Co., Limited's (HKG:6078) Shareholder Ownership Skewed Towards Insiders?
Nov 24Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Dec 31 2023 | CN¥2m | CN¥600k | CN¥683m |
| Sep 30 2023 | n/a | n/a | CN¥635m |
| Jun 30 2023 | n/a | n/a | CN¥587m |
| Mar 31 2023 | n/a | n/a | CN¥532m |
| Dec 31 2022 | CN¥4m | CN¥492k | CN¥477m |
| Sep 30 2022 | n/a | n/a | CN¥472m |
| Jun 30 2022 | n/a | n/a | CN¥468m |
| Mar 31 2022 | n/a | n/a | CN¥455m |
| Dec 31 2021 | CN¥709k | CN¥239k | CN¥441m |
| Sep 30 2021 | n/a | n/a | CN¥403m |
| Jun 30 2021 | n/a | n/a | CN¥365m |
| Mar 31 2021 | n/a | n/a | CN¥268m |
| Dec 31 2020 | CN¥45k | CN¥37k | CN¥170m |
| Sep 30 2020 | n/a | n/a | CN¥100m |
| Jun 30 2020 | n/a | n/a | CN¥29m |
| Mar 31 2020 | n/a | n/a | CN¥35m |
| Dec 31 2019 | CN¥779k | CN¥684k | CN¥40m |
Compensación vs. Mercado: La compensación total ($USD345.07K) de Yiwen está en línea con el promedio de empresas de tamaño similar en el mercado Hong Kong ($USD472.60K).
Compensación vs. Ingresos: La compensación de Yiwen ha sido consistente con los resultados de la empresa en el último año.
CEO
Yiwen Zhu (59 yo)
2.8yrs
Permanencia
CN¥2,493,000
Compensación
Mr. Yiwen Zhu serves as Executive Director & Co-Chief Executive Officer of at Hygeia Healthcare Holdings Co., Limited since August 23, 2021. He serves as Chairman of the Board at Hygeia Healthcare Holdings...
Equipo directivo
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Chairman & Co-CEO | 2.8yrs | CN¥2.49m | 44.38% CN¥ 10.3b | |
| Co-CEO & Executive Director | 2.8yrs | CN¥1.54m | sin datos | |
| Director of Research & Development | 4.3yrs | CN¥1.51m | 0.0051% CN¥ 1.2m | |
| Director of Radiotherapy Division & Executive Director | 3.4yrs | CN¥1.33m | sin datos | |
| Joint Company Secretary | no data | CN¥2.32m | 0.45% CN¥ 104.7m | |
| Financial Director | no data | sin datos | sin datos | |
| Joint Company Secretary | 3.3yrs | sin datos | sin datos |
3.3yrs
Permanencia media
41yo
Promedio de edad
Equipo directivo experimentado: El equipo directivo de 6078 se considera experimentado (3 años antigüedad media).
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Chairman & Co-CEO | 3.2yrs | CN¥2.49m | 44.38% CN¥ 10.3b | |
| Co-CEO & Executive Director | 4.9yrs | CN¥1.54m | sin datos | |
| Director of Research & Development | 4.3yrs | CN¥1.51m | 0.0051% CN¥ 1.2m | |
| Director of Radiotherapy Division & Executive Director | 3.4yrs | CN¥1.33m | sin datos | |
| Joint Company Secretary | 5.7yrs | CN¥2.32m | 0.45% CN¥ 104.7m | |
| Independent Non-Executive Director | 4.7yrs | CN¥240.00k | sin datos | |
| Independent Non-Executive Director | 2yrs | CN¥240.00k | sin datos | |
| Independent Non-Executive Director | 4.7yrs | CN¥240.00k | sin datos |
4.5yrs
Permanencia media
50yo
Promedio de edad
Junta con experiencia: La junta directiva de 6078 se considera experimentada (4.4 años de antigüedad promedio).